Summary:
The development and characterization of new receptor ligands for in vivo binding assays are often both lengthy and expensive. It is therefore desirable to predict the suitability of a ligand early in the process of its eval uation. In the present study, compartmental analysis fol lowing intracarotid ligand injection in the monkey is used to evaluate the in vivo kinetics of the muscarinic cholin ergic receptor antagonists rllCjtropanyl benzilate (["ClTRB) and ['I CjN-methylpiperidyl benzilate ([llCjNMPB) . Animals were implanted with chronic sub cutaneous access ports and indwelling catheters with tips located in the common carotid artery, just proximal to its bifurcation. The external carotid artery was ligated to en sure selective tracer delivery through the internal carotid artery to the brain. Positron emission tomography was used to measure brain tissue time-activity curves follow ing tracer injections. CBF was estimated from the clear ance of eSOjH20, and receptor ligand distributions were analyzed according to a physiologic model consisting of an intravascular compartment and nonspecific plus free and receptor-bound tissue ligand compartments. In ["ClTRB studies, marked reductions in the forward ligand-receptor binding rate and in both the total and the specific binding tissue-to-plasma volumes of ligand distri-
The initial selection of ligands for in vivo neurore ceptor imaging is often based on properties deter mined in in vitro binding assays. However, ligands with high equilibrium affinity or other favorable properties in vitro may prove unsuitable in vivo due to limitations in their kinetic distribution properties. This situation has been encountered in the biodis tributions of several tracers including buterophe-bution were observed after scopolamine receptor block ade or with low administered specific activity. Con versely, neither the distribution volume of the nonspecific plus free ligand compartment nor the rate of ligand dis sociation from receptor sites was affected. In ["CjNMPB studies, tissue compartments describing specific binding and non saturable components could not be reliably sep arated. The receptor-related term in this case, the total tissue-to-plasma distribution volume, demonstrated re duction after low specific activity ligand injection. Com parison of the two ligands suggests that NMPB interacts more rapidly with the receptors and has a lower apparent volume of distribution than does TRB. Thus, NMPB may be the more suitable ligand if accurate estimates of bind ing dissociation rate are limited by temporal constraints or if simplified, one-tis sue-compartment analyses are used. The carotid injection method appears promising for the initial evaluation of ligand kinetics, permitting physi ologic compartmental analyses without measurement of input functions or chromatography of blood samples. none binding to dopamine D 2 receptors (Wong et aI., 1986) and scopolamine (Frey et aI., 1992) , qui nuclidinyl iodobenzilate (Sawada et aI., 1990) , and benztropine (Dewey et aI., 1990) interactions with muscarinic cholinergic receptors. Scopolamine, for example, displays high in vitro equilibrium affinity for muscarinic cholinergic receptors (Kd = 300 pM) (Frey and Howland, 1992) . However, attempts to quantify brain muscarinic receptor density with [11Clscopolamine and positron emission tomogra phy (PET) demonstrate limited precision due to very rapid binding and slow dissociation of the ligand in vivo (Frey et aI., 1992) . Under conditions where binding is both relatively irreversible and rapid relative to tissue delivery and clearance, even delayed postmjection ligand distribution reflects tracer delivery (CBF and blood-brain barrier per meability) in addition to receptor density.
Precise in vivo receptor quantification requires ligands with well balanced ratios between the ki netic parameters describing blood-brain barrier ligand transport and binding to and dissociation from specific and nonspecific tissue sites. Consid ering that the development of a receptor ligand for human imaging use is both time consuming and costly, it is desirable to have a method for evalua tion of in vivo kinetics early in the development process. Here, we present an animal model employ ing intracarotid injection, PET data acquisition, and tracer kinetic analysis. Since the procedure utilizes direct intracarotid tracer injection, the need for measurement of the arterial input function, includ ing chromatographic analyses of blood, is obviated. The method is evaluated by application to a com parison of the ligands [ II C]tropanyl benzilate ([ II C]TRB) and e I C]N-methylpiperidyl benzilate ([ II C]NMPB), two muscarinic cholinergic tracers developed in our laboratories.
METHODS

In vivo receptor binding model
Modeling of in vivo radioligand binding studies gener ally employs a derivative of a four-compartment tracer kinetic model, including representations of radioligand in arterial plasma (CJ, free radioligand in tissue (Cr), radi oligand bound to nonspecific (nonsaturable) tissue sites (Cn S >, and radio ligand bound to specific (saturable) recep tor sites (Cs)' In the present studies, we have made the simplifying assumption that the free and nonspecific bind ing tissue pools are in rapid equilibrium, resulting in a three-compartment, four-parameter model with com bined representation of the non saturable binding and free ligand pools (Cns+r) (Frey et aI., 1985) . In this simplified model, movement of tracer between blood and tissue is described by transfer rate constants a and b, while bind ing of ligand to receptors is described by c and dissocia tion of bound tracer by d. The physiologic descriptions of the intercompartmental transfer rates have been derived previously (Frey et aI., 1985) and are given below:
where K I through k6 are the intercompartmental rate con stants in the four-compartment model (Fig. la) , a through d are the exchange rate constants in the simplified three compartment model ( Fig. 1 b) , PSis the cerebral capillary permeability-surface area product, EF is the single-pass cerebral capillary tracer extraction fraction, DVns is the apparent tissue volume of distribution of nonspecifically bound tracer (the ratio of the rates of binding and disso ciation from nonspecific sites), kon and koff represent the bimolecular binding and unimolecular dissociation rate constants for the receptor-ligand interaction, respec tively, and R is the concentration of receptors available for ligand binding. After bolus arterial input to the brain, the time course of the total tissue tracer concentration (C,) is described by
Implantation of chronic carotid artery access ports Chronic, indwelling vascular access ports (model GPV; Access Technologies, Skokie, IL, U.S.A.) were surgi cally implanted in each of three Macaca nemistrina mon keys under general anesthesia. The ports were connected to catheters entering the external carotid artery, termi nating in the common carotid artery as described previ ously (Taylor et aI., 1992) . Catheter tips were positioned at the carotid bifurcation, and the distal external carotid was ligated so that injections were directed into the inter nal carotid artery (Fig. 2) . Access ports were positioned subcutaneously over the sternum, facilitating percutane ous localization and ligand injections. The volume of the reservoir system and the catheter was �0.2 ml, and they were flushed on a once-or twice-weekly basis with a heparinized saline solution (�1 ml containing 1,000 U heparin sodium) to prevent thrombosis. Animals were used in tracer distribution experiments a minimum of 1 month postoperatively and participated in no more than 1 half-day imaging session per week over the course of the present studies. The studies were reviewed and approved by the University Committee on Use and Care of Ani mals, in accordance with the principles and guidelines established by the NIH Guide for the Care and Use of Laboratory Animals and the NIH OPRR Public Health Service Policy on Humane Care and Use of Laboratory Animals.
Determination of brain radiotracer time-activity curves
Prior to PET scanning sessions, animals were premed icated with atropine (0.04 mg/kg s.c.) to reduce oral se cretions and anesthetized with ketamine (25 mg/kg i.m., given every 30 min or more frequently as needed). Endo tracheal intubation was performed to prevent airway ob struction.
Imaging was performed with a Cyclotron Corp. TCC [150]H20 were injected and a 3-min emission image ac quired. After reconstruction, the subject's axial head po sition was adjusted to maximize the volume of the cath eter-perfused brain tissue in the center ring of the tomo graph.
CBF CBF was measured after bolus injection of eSO]H20.
Following the intracarotid bolus injection of 0.5-2 mCi of [ lsO]H20, total coincidence counts in the middle ring of the tomograph were recorded dynamically with high tem poral resolution. Data acquisition was started a few sec onds before tracer injection, and activity was integrated over contiguous 0.25-s intervals for 3 min, yielding a tis sue time-activity curve q(t). An integrated image of the activity was acquired in parallel with the count rate data and was reconstructed to verify the anatomy of the tissue contributing to the time-activity curve. The dynamic data were corrected for physical decay, and the following model was used to describe the time course of the tissue time-activity curve q(t):
where q is the total activity in a tissue volume element (here the whole-tissue slice in the field of view), CBF is cerebral blood flow to the volume, A is the tissue-to intravascular partition coefficient for water, C a(t) is the time course of arterial activity, and ® denotes the oper ation of convolution. Following direct intracarotid injec tion, the shape of the arterial input curve may be assumed to be a true impulse (neglecting effects of intravascular bolus dispersion and assuming no recirculation), in which case Eq. 8 can be simplified to
where q(O) is the activity initially extracted by the tissue volume. The constant CBF!� was calculated by fitting Eq. 9 to the tissue time-activity curve between 5 and 35 s following the peak of activity. and CBF was estimated by assuming a partition coefficient � of 0.85 mllg (Fig. 3 ).
Estimation of in vivo ligand distribution and binding parameters
IIC-labeled TRB and NMPB were synthesized from the desmethyl precursors and e ICjmethyl iodide as de scribed previously (Mulholland et aI., 1992 (Mulholland et aI., , 1995 . The specific activity of each tracer was determined by ultra violet absorbtiometry following HPLC of the reaction mixtures.
Following the bolus injection of 1-3 mCi of either [IIC]TRB or [IIC]NMPB, coincidence counts in the mid dle ring of the tomograph were recorded as in the CBF studies and the data corrected for decay. A monoexpo nential was fitted to the time-activity curve in the interval between 5 and 35 s after initial arrival of activity in the head and the fit back-extrapolated to the time of peak activity. The EF was calculated as the ratio of the back extrapolated value at the time of the peak-to-peak activity (Eichling et aI., 1974; Taylor et aI., 1992) . The forward transport rate from blood to brain (Kl; parameter a) was then estimated from Eq. 1, employing the immediately preceding CBF value.
Simultaneously with the TRB or NMPB injection, a sequence of PET scans was started consisting of the fol lowing: 7 x 5 s, 12 x 10 s, 14 x 30 s, 10 x 120 s, 6 x 300 s, and 3 x 600 s scan frames. The data were corrected for IIC decay, and each frame was reconstructed into five transaxial slices using a 128 x 128 voxel matrix (voxel size: 1.4 x 1.4 x 11.5 mm, reconstructed with Hanning filter, cutoff frequency 1.75 cycles/cm, resulting in an ef fective in-plane resolution of 12 mm and z-axis resolution of 10 mm full width at half-maximum). Tissue time- activity curves were generated by placing large regions of interest over the cerebral activity on the injected side in the middle slice and also in the same approximate loca tion on the contralateral (uninjected) side. The time activity curves were analyzed by fitting to Eqs. 1-7 with a nonlinear, least-squares algorithm (Marquardt, 1963) , with weighting inverse to the counts recorded at each point. Parameter a was fixed to the value determined from the first-pass extraction and CBF estimates (see pre ceding). This fitting procedure yielded the parameters b, e, and d. The fit was started 10 s after the peak, permitting the bolus of intravascular activity to leave the field of view and obviating the need to include and fit an intra vascular volume term.
In addition to the forward binding rate parameter c, several derived estimates of ligand binding and distribu tion were examined. The specific binding distribution vol ume (DVJ (Koeppe et aI., 1991) , the total tissue ligand distribution volume (DVtot) , and the nonsaturable (nonspecific plus free ligand) distribution volume (DVns+f) were each esti mated as follows:
DVs =d= j= f
where BP is the binding potential (BP = Bma)Kd), fis the free fraction of ligand in the tissue binding precursor pool, and Kd is the equilibrium binding affinity constant (Kd = kon/koff) in the notation of Mintun et al. (1984) .
RESULTS
[llC]TRB distribution
Following intracarotid Injection of high specific activity tracer (containing <0. 3 nmol), [l I C]TRB demonstrated protracted brain retention with grad ual clearance over the experimental period (Fig. 4) . The cerebral retention time of TRB was consider ably shortened either after injection of low specific activity tracer (containing >6 nmol TRB) or when unlabeled scopolamine was given systemically prior to tracer injection. II C-labeled TRB entered the brain readily follow ing intracarotid injection. Estimates of its first-pass extraction (EF) ranged from 0.83 to 0. 99 (average 0.90). Kinetic compartmental analyses of [l I C]TRB distribution indicated clear resolution of two tissue compartments in the high specific activity studies (Table 1 ). The parameter estimates indicated pre dominance of receptor binding in the cerebral re tention of TRB with DV s of �20 mIlg and a nonsat urable binding distribution volume (DVn s+f) of �5 mllg. Individual intercompartmental transfer rate constants indicated a forward binding rate (param eter c) approximately three times the magnitude of the tissue-to-blood clearance rate constant (param eter b); however, all of the primary and secondarily derived parameter values were within physiologi cally reasonable ranges and revealed adequate pre cision across repeated studies. In the instances of low specific activity injections or following sys temic scopolamine blockade of muscarinic recep tors (0.4 mg/kg scopolamine HCI i. v. 15 min prior to tracer injection), analyses revealed little effect on the model parameters unrelated to receptor binding. Only the forward binding rate parameter c, DV s p, and DVtot were altered, each demonstrating consid erable reduction in comparison with the high spe cific activity studies.
[ ll C]NMPB distribution
Similarly to [llC]TRB, e lC]NMPB was readily extracted by brain from the circulation (average EF 0.94). In distinction from [11C]TRB, ["C]NMPB was more rapidly lost from brain after initial uptake (data not shown), and kinetic analyses revealed in consistent and physiologically untenable individual model parameter estimates when attempts were made to resolve two tissue compartments. In two of the three studies, a monoexponential tissue re sponse function provided equivalent description of the tissue time-activity curves as did the biexpo nential response function in Eq. 5. As a result, only the tracer extraction and DVtot parameters are given for NMPB (Table 1 ). The DVtot of ["C]NMPB is less than that of [ II C]TRB (�85 mllg for NMPB vs. 100 mllg for TRB), in agreement with the qualitative observation of less avid brain retention of NMPB.
J Cereb Blood Flow Metab. Vol. 16, No.6, 1996 After injection of low specific activity [ II C]NMPB, there was considerable reduction in DVtot, reflect ing its sensitivity to receptor availability .
DISCUSSION
In the present studies, we have developed and evaluated a new animal model for characterization of in vivo binding site imaging radioligands. Use of direct intracarotid injection after acute transfemoral catheterization was introduced and employed ex tensively by Raichle and collaborators to determine blood-brain barrier penetration of radiotracers such as [150]H20 and "C-Iabeled alcohols Raichle et al., 1974 Raichle et al., , 1976 . More recently, intracarotid injection has been applied in studies of the kinetic behavior of the single photon emission computed tomography perfusion tracers [99mTc]_ T691 (Taylor et al., 1992) and [99mTc ]bicisate (Fri berg et al. , 1994) . Our modification of the acute catheterization procedure, with an implanted infu sion port system, provides reliable access with less time and expensc, eliminating the need for angio graphic catheter positioning at each session. Over all, the chronic catheterization procedure was well toleratcd by the monkeys and the port systems re mained patent for at least 6 months, requiring only once-or twice-weekly flushing with heparinized sa line.
Previous experience in our laboratories indicates that in vitro evaluation and systemic biodistribution studies in rodent models alone may be misleading with regard to the subsequent quantitative utility of radiotracers in clinical research applications. Ki netic aspects of radioligand distribution dictate both the form of the compartmental model and the math ematical approach to estimation of binding site den sity (Pennell and Frey, 1994) , as well as the accu racy and precision of the measures (Koeppe, 1990) . Thus, the method developed in our current studies may be of considerable importance early in tracer development. Specific factors governing the overall utility of a tracer for in vivo brain imaging include (a) uptake from blood to brain, (b) kinetics of inter action between the ligand and both specific and nonspecific binding sites, and (c) ligand metabo lism. Of these, the first two are readily obtained with the current procedure.
Practical advantages of employing the current method early in the course of radioligand develop ment include the ability to evaluate details of tracer kinetic distribution with relatively small amounts of radiotracer and the lack of need for measurement or metabolite correction of arterial blood. In contrast, min prior to tracer injection; (-), transfer coefficients interrelating tissue compartments could not be reliably estimated following NMPB injection. Only blood-brain barrier transport and the total tissue volume of distribution parameters are given. kinetic brain distributions following systemic tracer injections require 5-to 10-fold higher administered doses of radioactivity to achieve comparable tissue counting statistics. More importantly, when admin istered by the intravenous route, the arterial tracer input function is often protracted and consists of both authentic tracer as well as its radiolabeled me tabolites. Accurate kinetic analyses must therefore extend the period of experimental observation as well as rely on sampled, metabolite-corrected arte rial input functions. These requirements add sub stantial time and cost to tracer evaluation, in some instances leading to agents with only limited poten tial for quantitative clinical.use.
Determination of blood-to-brain transport
The method for estimation of blood-brain barrier transport in the current experimental design was initially developed for the study of radiolabeled wa ter and alcohol extractions (Eichling et aI., 1974; Raichle et aI., 1976) . It assumes that the peak tissue activity after bolus arterial tracer injection repre sents the intravascular concentration driving the diffusion into the tissue compartments. With this assumption, the first-pass extraction fraction (EF) can be estimated as the ratio of initially extracted tracer to the total peak activity. As opposed to prior methods employing direct tracer injection into the intracranial internal carotid, our more proximal site of injection and use of larger volumes to overcome the void volume of the reservoir system may have led to a more temporally dispersed arterial input. The effect of temporal dispersion on our parameter estimates is predictably greatest on EF and will re sult in increased estimates particularly for poorly extracted tracers (Taylor et aI., 1992) . In our for mulation, we have combined this EF measure for the receptor ligands with immediately preceding es timations of CBF, resulting in a measure of the combined convective and diffusive contributions to the model transport parameter K\, but without the need for sampling of the arterial tracer input func tion. While errors in EF estimation result in linearly scaled errors in model parameter a and in D V ns + f and D Vtot , there is no propagation of this effect into estimates of the remaining model parameters or of DV s '
A limitation of the present experimental design is the potential for overlooking significant effects of plasma protein or blood cell interactions with the ligand. We have determined in human studies, for example, that the apparent first-pass extraction of [IlC] TRB is in the range of 0. 25-0.30 (Koeppe et aI., 1994) . This lower value than that found in the present studies may reflect reduced cerebral capil lary surface area for diffusion in the human as op posed to the monkey brain or, more likely, may indicate that binding of TRB to blood components limits its brain uptake after intravenous injection. This latter speculation is further supported by the lipophilicity of the tracers (octanol-to-saline parti tion coefficients for free bases: TRB = 516, NMPB = 35; unpublished observations) and prior obser vations that tracers of similar lipophilic character are quantitatively extracted at the primate blood brain barrier (Dischino et aI., 1983) . Tracer injec tions from buffered saline vehicle solutions, as con ducted in the present studies, may provide an upper limit to ligand transport rates. Additional studies with tracer injected after incubation with both plasma and whole blood could be conducted to de termine directly their effects on blood-brain barrier transport (Pardridge, 1979; Pardridge and Fierer, 1990) . Alternatively, the binding of ligand to plasma proteins and blood cells can be estimated in vitro, providing a lower limit for free tracer fractions available for transport if dissociation of bound tracer is negligible during capillary transit.
Brain tissue distribution kinetics
The parameters b-d in our present formulation describe the tissue distribution and ligand binding kinetics and determine only the shape of the tissue time-activity curve (see Eq. 5). Thus, if the blood brain barrier transport rate is not of interest, rela tive tissue distribution kinetics can be calculated independently of K1• This may be of use, for exam ple, in screening ligands for suitability in "equilib rium" versus "irreversible" binding models (Pen nell and Frey, 1994) .
The substantial reductions in the forward binding rate model parameter and in both specific binding and total tissue volumes of distribution following receptor blockade and with low radiotracer specific activity verify appropriate saturability of binding parameters. Parameters b and d were relatively un affected by these pharmacological interventions, as is expected, since they represent clearance of free ligand from tissue and dissociation of ligand from receptors, respectively.
In addition to appropriate sensitivity and speci ficity of parameters to available receptor numbers, the relative and absolute values of the tissue distri bution rate parameters for l II C]TRB are in good agreement with those determined in kinetic analy ses of human brain following intravenous injection.
The mean k4 value ofO.02/min in the present studies is identical to that determined in humans (Koeppe et aI., 1994) . Also in close agreement with the hu man study is the ratio of c to b, which ranged from 2.7 to 4. 1 in the current high specific activity studies and is 2.5-3.5 in the human. The present results further suggest that e I C]NMPB, in comparison with [ II C]TRB, may have better sensitivity to receptor numbers in areas of highest concentra tion (cerebral cortex and striatum), owing to its lower DVtot' The more rapid kinetic interaction of [ II C]NMPB with receptors, precluding kinetic res olution of specific binding from nonsaturable com ponents, indicates that its distribution may be ap propriately analyzed with reversible, equilibrium models. Our preliminary human studies with [ II C]NMPB (Zubieta et aI., 1992) support this inter pretation.
It is of interest, and also of some concern, that we were able to easily detect the effects of reduced ligand specific activity on tracer kinetics. Occu pancy of a significant receptor fraction is predicted following our low specific activity injections if one assumes that monkey forebrain muscarinic recep tors are present at a concentration of -500 fmol/mg and that the internal carotid artery supplies -70 ml of brain tissue in M. nemistrina. Thus, there are an estimated 3.5 nmol of receptor and initially ex-J Cereb Blood Flow Metab. Vol. 16. No.6, 1996 tracted radiopharmaceutical doses of 0. 15-0.35 nmol in the high specific activity and 5-8.6 nmol in the low specific activity studies. In these latter in stances, the modeling assumption of a constant re ceptor availability, and thus of constant rate coef ficients in the compartmental model, is violated. Accounting for receptor saturation effects on the model parameters requires assumption that the total tissue receptor concentration (BmaJ is equal to the unoccupied receptor concentration (R) at the begin ning of a scan in the absence of significant occu pancy by endogenous substances (neurotransmit ter) or unlabeled drugs. If only a small fraction of the available receptors become occupied during the experiment, R remains essentially constant during the study and Eq. 3 is valid. If, however, significant receptor occupancy occurs, R becomes time depen dent. The saturability of the specific binding tissue compartment C s and effect on model parameter c can be expressed as kon[Bmax -Cs(t)/SA] e(t) = 1 + DV (13) ns where SA is the ligand specific activity, Bmax is the density of free receptors at the beginning of the ex periment (Rt=o), and C s (t) is the concentration of specifically bound ligand at time t postinjection. We evaluated the nonconstant coefficient differential equations governing receptor-saturating conditions with numerical integration (data not shown), but found, as reported previously by Mintun et al. (1984) , that the data were described equally well by the constant coefficient model (no improvement in residuals or reduced X 2 with the nonconstant coef ficient model). Hence, analyses of the time-activity curves alone following carotid tracer injection will not exclude the possibility of partial saturation due to low tracer specific activity. It is thus important to accurately estimate both injected tracer and avail able receptor specific activities in these studies.
Summary
In conclusion, the intracarotid injection method is suitable for kinetic evaluation of receptor ligands at an early stage in their development. It has the advantages of minimal invasiveness after initial sur gical port implantation and simple data analyses. Critical indicators that dictate whether a ligand is suitable for equilibrium binding or irreversible bind ing models, as well as indicators of relative sensi tivity to binding site number (relative magnitudes of parameters b, c, and d), can be accurately deter mined. The ability to evaluate tracer kinetic behav ior in detail, without the need for large-scale radio-syntheses or for metabolite correction of arterial plasma input functions, may considerably stream line the future evaluation of radioligands for poten tial in vivo application.
